Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion - The Wall Street Journal
wsj.comSubmitted by thewallstreetjournal7221 in business
Swiss pharmaceutical giant seeks to bolster pipeline
Submitted by thewallstreetjournal7221 in business
Swiss pharmaceutical giant seeks to bolster pipeline